NCT02301130 2024-04-25Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid TumorsKyowa Kirin Co., Ltd.Phase 1 Completed64 enrolled
NCT02444793 2019-02-27A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid TumorsPfizerPhase 1 Terminated24 enrolled 34 charts